Sponsor

Gottsegen National Cardiovascular Center

Hungary Kerulet, Haller Utca 29/IX., IX. Kerulet, 1096 Budapest, Hungary

About the sponsor

The Gottsegen National Cardiovascular Center in Budapest focuses on atrial fibrillation research, with particular interest in the management of persistent symptomatic atrial fibrillation and the prevention of recurrent atrial tachyarrhythmia.

Atrial fibrillation treatment
Cardiac rhythm control
Arrhythmia recurrence prevention

Its clinical research activity is centred on interventions that address early disease control in patients with ongoing AF.

About Specializations

Gottsegen National Cardiovascular Center runs clinical trials in conditions such as Cardiac ablation, among others.

Cardiac ablation

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Cardiac ablation

Recruiting

Registered drugNo placebo

Study on Early Treatment of Persistent Atrial Fibrillation: Comparing Cryoballoon Therapy with Dronedarone, Flecainide, Sotalol, and Propafenone in Symptomatic Patients

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Dronedarone
Sponsor:Gottsegen National Cardiovascular Center

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →